French Diatos Elected Among the 15 Emerging Biotech Companies 2004 for Its Innovative Technologies and International Developmen
FierceBiotech Editor-in-chief John D. Carroll lauded Diatos's research efforts in 2004, saying "Diatos has pioneered two technologies for cancer and other life-threatening diseases, and is preparing to advance its innovative therapeutic products into clinical trials."
"FierceBiotech is well-known for its coverage of biotech trends and successful business strategies," said Dr. John Tchelingerian, President and Chief Executive Officer of Diatos. "Being selected as a member of The Fierce 15 is an honor that recognizes Diatos's emerging international presence in the biotech industry."
The Fierce 15 celebrates the spirit of being "fierce" - daring to be innovative and aggressive, even in an industry with a long time-to-market. The list of Fierce 15 companies is available in today's issue of FierceBiotech and on their web site at www.fiercebiotech.com.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.